Quality control and analytical methods for baculovirus-based products

Journal of Invertebrate Pathology

Volumn 107, Issue SUPPL., 2011, Pages

  Roldão, António ^a,b,d   Vicente, Tiago ^a,b,e   Peixoto, Cristina ^b   Carrondo, Manuel J T ^b,c   Alves, Paula M ^a,b  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^d CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^e Redbiotec   (Switzerland)

Author keywords

Biosafety and efficacy; Engineering technologies; Quality control; Recombinant baculovirus; Up and down stream processing

Indexed keywords

VIRUS VACCINE;

ANIMAL; ARMYWORM; BACULOVIRUS; BIOENGINEERING; CELL CULTURE; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHARMACEUTICS; QUALITY CONTROL; REVIEW; STANDARD; VIROLOGY;

ANIMALS; BACULOVIRIDAE; BIOENGINEERING; CELLS, CULTURED; GENE THERAPY; GENETIC VECTORS; HUMANS; QUALITY CONTROL; SPODOPTERA; TECHNOLOGY, PHARMACEUTICAL; VIRAL VACCINES;

EID: 79960636554     PISSN: 00222011     EISSN: 10960805     Source Type: Journal    
DOI: 10.1016/j.jip.2011.05.009     Document Type: Review

References (120)

1. Ahn M.-H., Song M., Oh E.-Y., Jamal A., Kim H.S., Ko K., Choo Y.-K., Kim B.-J., Ko K. Production of therapeutic proteins with baculovirus expression system in insect cell. Entomol. Res. 2008, 38(S1):71-78.
2. Airenne K.J., Mähönen A.J., Laitinen O.H., Ylä-Herttuala S. Baculovirus-Mediated Gene Transfer: An Emerging Universal Concept. Gene and Cell Therapy: Therapeutic mechanisms and strategies 2009, CRC Press, N.S. Templeton. Boca Raton, FL, pp. 263-291. third ed.
3. Aiuti A., Cattaneo F., Galimberti S., Benninghoff U., Cassani B., Callegaro L., Scaramuzza S., Andolfi G., Mirolo M., Brigida I., Tabucchi A., Carlucci F., Eibl M., Aker M., Slavin S., Al-Mousa H., Al Ghonaium A., Ferster A., Duppenthaler A., Notarangelo L., Wintergerst U., Buckley R.H., Bregni M., Marktel S., Valsecchi M.G., Rossi P., Ciceri F., Miniero R., Bordignon C., Roncarolo M.G. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N. Engl. J. Med. 2009, 360(5):447-458.
4. Artenstein A.W., Grabenstein J.D. Smallpox vaccines for biodefense: need and feasibility. Expert Rev. Vaccines 2008, 7(8):1225-1237.
5. Barsoum, J., 1999. Concentration of recombinant baculovirus by cation-exchange chromatography. Biotechniques 26(5), 834-836, 838, 840.
6. Belyaev A.S., Roy P. Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells. Nucleic Acids Res. 1993, 21(5):1219-1223.
7. Bernal V., Carinhas N., Yokomizo A.Y., Carrondo M.J., Alves P.M. Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism. Biotechnol. Bioeng. 2009, 104(1):162-180.
8. Blagborough A.M., Yoshida S., Sattabongkot J., Tsuboi T., Sinden R.E. Intranasal and intramuscular immunization with baculovirus dual expression system-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission. Vaccine 2010, 28(37):6014-6020.
9. Boeckle S., Wagner E. Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems. AAPS J. 2006, 8(4):E731-E742.
10. Boyce F.M., Bucher N.L. Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. USA 1996, 93(6):2348-2352.
11. Burgess S. Molecular weights of lepidopteran baculovirus DNAs: derivation by electron microscopy. J. Gen. Virol. 1977, 37:501-510.
12. Burnett J.R., Hooper A.J. Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiency. Curr. Opin. Mol. Ther. 2009, 11(6):681-691.
13. Carinhas N., Bernal V., Monteiro F., Carrondo M.J., Oliveira R., Alves P.M. Improving baculovirus production at high cell density through manipulation of energy metabolism. Metab. Eng. 2009, 12(1):39-52.
14. Cha H.J., Gotoh T., Bentley W.E. Simplification of titer determination for recombinant baculovirus by green fluorescent protein marker. BioTechniques 1997, 23(5):782-786.
15. Chapple S.D., Jones I.M. Non-polar distribution of green fluorescent protein on the surface of Autographa californica nucleopolyhedrovirus using a heterologous membrane anchor. J. Biotechnol. 2002, 95(3):269-275.
16. Chase H.A. Purification of proteins by adsorption chromatography in expanded beds. Trends Biotechnol. 1994, 12(8):296-303.
17. Chuang C.K., Sung L.Y., Hwang S.M., Lo W.H., Chen H.C., Hu Y.C. Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering. Gene Ther. 2007, 14(19):1417-1424.
18. Cox M.M.J., Hashimoto Y. A fast track influenza virus vaccine produced in insect cells. J. Invertebr. Pathol. 2011, 107:S31.
19. Cox M.M., Hollister J.R. FluBlok, a next generation influenza vaccine manufactured in insect cells. Biologicals 2009, 37(3):182-189.
20. Cruz P.E., Cunha A., Peixoto C.C., Clemente J., Moreira J.L., Carrondo M.J. Optimization of the production of virus-like particles in insect cells. Biotechnol. Bioeng. 1998, 60(4):408-418.
21. Cruz P.E., Martins P.C., Alves P.M., Peixoto C.C., Santos H., Moreira J.L., Carrondo M.J. Proteolytic activity in infected and noninfected insect cells: degradation of HIV-1 Pr55gag particles. Biotechnol. Bioeng. 1999, 65(2):133-143.
22. Cruz P.E., Peixoto C.C., Moreira J.L., Carrondo M.J.T. Production and quality analysis of Pr55gag particles produced in baculovirus-infected insect cells. J. Chem. Technol. Biotechnol. 1999, 72(2):149-158.
23. Davis T.R., Wood H.A. Intrinsic glycosylation potentials of insect cell cultures and insect larvae. In Vitro Cell. Dev. Biol. Anim. 1995, 31(9):659-663.
24. DePalma A. Designing better purification schemes overcoming the impracticalities of downstream single-use systems. Gen. Eng. News 2007, 27:13.
25. Draeger N.M., Chase H.A. Liquid fluidized bed adsorption of protein in the presence of cells. Bioseparation 1991, 2(2):67-80.
26. FDA, 2010. Center for Biologics Evaluation and Research Guidelines.
27. Ferris M.M., Stepp P.C., Ranno K.A., Mahmoud W., Ibbitson E., Jarvis J., Cox M.M., Christensen K., Votaw H., Edwards D.P., Rowlen K.L. Evaluation of the Virus Counter((R)) for rapid baculovirus quantitation. J. Virol. Methods 2011, 171(1):111-116.
28. Fischlechner M., Donath E. Viruses as building blocks for materials and devices. Angew. Chem. Int. Ed. Engl. 2007, 46(18):3184-3193.
29. Fitzgerald D.J., Berger P., Schaffitzel C., Yamada K., Richmond T.J., Berger I. Protein complex expression by using multigene baculoviral vectors. Nat. Methods 2006, 3(12):1021-1032.
30. Franco C.F., Mellado M.C., Alves P.M., Coelho A.V. Monitoring virus-like particle and viral protein production by intact cell MALDI-TOF mass spectrometry. Talanta 2010, 80(4):1561-1568.
31. Fraser M.J. Ultrastructural observations of virion maturation in Autographa californica nuclear polyhederosis virus infected Spodoptera frugiperda cell cultures. J. Ultrastruct. Mol. Struct. Res. 1986, 95(1-3):189-195.
32. Fromentin R., Majeau N., Laliberte Gagne M.E., Boivin A., Duvignaud J.B., Leclerc D. A method for in vitro assembly of hepatitis C virus core protein and for screening of inhibitors. Anal. Biochem. 2007, 366(1):37-45.
33. Galibert L., Merten O.-W. Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases. J. Invertebr. Pathol. 2011, 107:S80.
34. Gao G., Zhou X., Alvira M.R., Tran P., Marsh J., Lynd K., Xiao W., Wilson J.M. High throughput creation of recombinant adenovirus vectors by direct cloning, green-white selection and I-Sce I-mediated rescue of circular adenovirus plasmids in 293 cells. Gene Ther. 2003, 10(22):1926-1930.
35. Georgopoulos L.J., Elgue G., Sanchez J., Dussupt V., Magotti P., Lambris J.D., Totterman T.H., Maitland N.J., Nilsson B. Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood. Mol. Immunol. 2009, 46(15):2911-2917.
36. Ghosh S., Parvez M.K., Banerjee K., Sarin S.K., Hasnain S.E. Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy. Mol. Ther. 2002, 6(1):5-11.
37. Grabowska A.K., Lipinska A.D., Rohde J., Szewczyk B., Bienkowska-Szewczyk K., Rziha H.J. New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection. Vaccine 2009, 27(27):3584-3591.
38. Gu S., Pan S., Bradbury E.M., Chen X. Precise peptide sequencing and protein quantification in the human proteome through in vivo lysine-specific mass tagging. J. Am. Soc. Mass Spectrom. 2003, 14(1):1-7.
39. Guibinga G.H., Friedmann T. Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein. Mol. Ther. 2005, 11(4):645-651.
40. Hink W.F., Vail P.V. A plaque assay for titration of alfalfa looper nuclear polyhedrosis virus in a cabbage looper (TN-368) cell line. J. Invertebr. Pathol. 1973, 22:168-174.
41. Hitchman R.B., Possee R.D., Crombie A.T., Chambers A., Ho K., Siaterli E., Lissina O., Sternard H., Novy R., Loomis K., Bird L.E., Owens R.J., King L.A. Genetic modification of a baculovirus vector for increased expression in insect cells. Cell Biol. Toxicol. 2010, 26(1):57-68.
42. Hjorth R. Expanded-bed adsorption in industrial bioprocessing: recent developments. Trends Biotechnol. 1997, 15(6):230-235.
43. Hober S., Nord K., Linhult M. Protein A chromatography for antibody purification. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007, 848(1):40-47.
44. Hofmann C., Strauss M. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther. 1998, 5(4):531-536.
45. Hong S., Hwang D.-Y., Yoon S., Isacson O., Ramezani A., Hawley R.G., Kim K.-S. Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Mol. Ther. 2007, 15(9):1630-1639.
46. Hu Y.C. Baculovirus vectors for gene therapy. Adv. Virus Res. 2006, 68:287-320.
47. Hu Y.C., Yao K., Wu T.Y. Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev. Vaccines 2008, 7(3):363-371.
48. Janakiraman V., Forrest W.F., Chow B., Seshagiri S. A rapid method for estimation of baculovirus titer based on viable cell size. J. Virol. Methods 2006, 132(1-2):48-58.
49. Jang J.D., Sanderson C.S., Chan L.C., Barford J.P., Reid S. Structured modeling of recombinant protein production in batch and fed-batch culture of baculovirus-infected insect cells. Cytotechnology 2000, 34(1-2):71-82.
50. Jiang B., Estes M.K., Barone C., Barniak V., O'Neal C.M., Ottaiano A., Madore H.P., Conner M.E. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Vaccine 1999, 17(7-8):1005-1013.
51. Jorio H., Tran R., Kamen A. Stability of serum-free and purified baculovirus stocks under various storage conditions. Biotechnol. Prog. 2006, 22:319-325.
52. Kaikkonen M.U., Viholainen J.I., Narvanen A., Yla-Herttuala S., Airenne K.J. Targeting and purification of metabolically biotinylated baculovirus. Hum. Gene Ther. 2008, 19(6):589-600.
53. Kalbfuss B., Wolff M., Morenweiser R., Reichl U. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnol. Bioeng. 2007, 96(5):932-944.
54. Kang S.M., Song J.M., Quan F.S., Compans R.W. Influenza vaccines based on virus-like particles. Virus Res. 2009, 143(2):140-146.
55. Karger A., Bettin B., Granzow H., Mettenleiter T.C. Simple and rapid purification of alphaherpesviruses by chromatography on a cation exchange membrane. J. Virol. Methods 1998, 70(2):219-224.
56. Karkkainen H.R., Lesch H.P., Maatta A.I., Toivanen P.I., Mahonen A.J., Roschier M.M., Airenne K.J., Laitinen O.H., Yla-Herttuala S. A 96-well format for a high-throughput baculovirus generation, fast titering and recombinant protein production in insect and mammalian cells. BMC Res. Notes 2009, 2:63.
57. Kim Y.K., Park I.K., Jiang H.L., Choi J.Y., Je Y.H., Jin H., Kim H.W., Cho M.H., Cho C.S. Regulation of transduction efficiency by pegylation of baculovirus vector in vitro and in vivo. J. Biotechnol. 2006, 125(1):104-109.
58. Kinnunen K., Kalesnykas G., Mahonen A.J., Laidinen S., Holma L., Heikura T., Airenne K., Uusitalo H., Yla-Herttuala S. Baculovirus is an efficient vector for the transduction of the eye: comparison of baculovirus- and adenovirus-mediated intravitreal vascular endothelial growth factor D gene transfer in the rabbit eye. J. Gene Med. 2009, 11(5):382-389.
59. Kompier R., Tramper J., Vlak J.M. A continuous process for the production of baculovirus using insect cell cultures. Biotechnol. Lett. 1988, 10:849-854.
60. Konz J.O., Lee A.L., Lewis J.A., Sagar S.L. Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell DNA. Biotechnol. Prog. 2005, 21(2):466-472.
61. Liu Y.K., Yang C.J., Liu C.L., Shen C.R., Shiau L.D. Using a fed-batch culture strategy to enhance rAAV production in the baculovirus/insect cell system. J. Biosci. Bioeng. 2010, 110(2):187-193.
62. Mahonen A.J., Makkonen K.E., Laakkonen J.P., Ihalainen T.O., Kukkonen S.P., Kaikkonen M.U., Vihinen-Ranta M., Yla-Herttuala S., Airenne K.J. Culture medium induced vimentin reorganization associates with enhanced baculovirus-mediated gene delivery. J. Biotechnol. 2010, 145(2):111-119.
63. Maranga L., Cunha A., Clemente J., Cruz P., Carrondo M.J. Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity. J. Biotechnol. 2004, 107(1):55-64.
64. Meghrous J., Aucoin M.G., Jacob D., Chahal P.S., Arcand N., Kamen A.A. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor. Biotechnol. Prog. 2005, 21(1):154-160.
65. Mellado M.C., Franco C., Coelho A., Alves P.M., Simplicio A.L. Sodium dodecyl sulfate-capillary gel electrophoresis analysis of rotavirus-like particles. J. Chromatogr. A 2008, 1192(1):166-172.
66. Mellado M.C.M., Mena J.A., Lopes A., Ramírez O.T., Carrondo M.J.T., Palomares L.A., Alves P.M. Impact of physicochemical parameters on in vitro assembly and disassembly kinetics of recombinant triple-layered rotavirus-like particles. Biotechnol. Bioeng. 2009, 104(4):674-686.
67. Mena J., Ramirez O.T., Palomares L. Titration of non-occluded baculovirus using a cell viability assay. BioTechniques 2003, 34(2):260-264.
68. Mena J.A., Ramirez O.T., Palomares L.A. Quantification of rotavirus-like particles by gel permeation chromatography. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2005, 824(1-2):267-276.
69. Mlambo G., Kumar N., Yoshida S. Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen. Vaccine 2010, 28(43):7025-7029.
70. Morris T.D., Miller L.K. Promoter influence on baculovirus-mediated gene expression in permissive and nonpermissive insect cell lines. J. Virol. 1992, 66(12):7397-7405.
71. Oker-Blom C., Airenne K.J., Grabherr R. Baculovirus display strategies: emerging tools for eukaryotic libraries and gene delivery. Brief Funct. Genomic Proteomic 2003, 2(3):244-253.
72. O'Reilly D.R., Miller A.D., Luckow V.A. Baculovirus Expression Vectors: A Laboratory Manual 1994, Oxford University Press, New York, USA.
73. Palomares L.A., Estrada-Mondaca S., Ramírez O. Principles and Applications of the Insect Cell-Baculovirus Expression Vector System 2006, Taylor and Francis, New York, USA.
74. Parry S., Koi H., Strauss J.F. Transplacental drug delivery: gene and virus delivery to the trophoblast. Adv. Drug Deliv. Rev. 1999, 38(1):69-80.
75. Peixoto C., Sousa M.F., Silva A.C., Carrondo M.J., Alves P.M. Downstream processing of triple layered rotavirus like particles. J. Biotechnol. 2007, 127(3):452-461.
76. Pijlman G.P., van Schijndel J.E., Vlak J.M. Spontaneous excision of BAC vector sequences from bacmid-derived baculovirus expression vectors upon passage in insect cells. J. Gen. Virol. 2003, 84(Pt 10):2669-2678.
77. Pijlman G.P., de Vrij J., van den End F.J., Vlak J.M., Martens D.E. Evaluation of baculovirus expression vectors with enhanced stability in continuous cascaded insect-cell bioreactors. Biotechnol. Bioeng. 2004, 87(6):743-753.
78. Possee R.D., King L.A. The Baculovirus Expression System: A laboratory guide 1992, Chapman & Hall, London, UK. first ed.
79. Richards A., Matthews M., Christian P. Ecological considerations for the environmental impact evaluation of recombinant baculovirus insecticides. Annu. Rev. Entomol. 1998, 43:493-517.
80. Roldao A., Vieira H.L.A., Alves P.M., Oliveira R., Carrondo M.J.T. Intracellular dynamics in rotavirus-like particles production: evaluation of multigene and monocistronic infection strategies. Process Biochem. 2006, 41(10):2188-2199.
81. Roldao A., Vieira H.L., Charpilienne A., Poncet D., Roy P., Carrondo M.J., Alves P.M., Oliveira R. Modeling rotavirus-like particles production in a baculovirus expression vector system: Infection kinetics, baculovirus DNA replication, mRNA synthesis and protein production. J. Biotechnol. 2007, 128(4):875-894.
82. Roldao A., Carrondo M.J.T., Alves P.M., Oliveira R. Stochastic simulation of protein expression in the baculovirus/insect cells system. Comput. Chem. Eng. 2008, 32(1-2):68-77.
83. Roldao A., Oliveira R., Carrondo M.J., Alves P.M. Error assessment in recombinant baculovirus titration: evaluation of different methods. J. Virol. Methods 2009, 159(1):69-80.
84. Roldao A., Mellado M.C., Castilho L.R., Carrondo M.J., Alves P.M. Virus-like particles in vaccine development. Expert Rev. Vaccines 2010, 9(10):1149-1176.
85. Roldao A., Silva A.C., Mellado M.C.M., Alves P.M., Carrondo M.J.T. Viruses and virus-like particles in biotechnology: fundamentals and applications. Scientific Fundamentals in Biotechnology 2011, Vol. 1. Elsevier, Oxford, USA. 2nd ed. M. Moo-Young, M. Butler, C. Webb, A. Moreira, B. Grodzinski, Z.F. Cui, S. Agathos (Eds.).
86. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Press, NY, USA. second ed.
87. Shen C.F., Meghrous J., Kamen A. Quantitation of baculovirus particles by flow cytometry. J. Virol. Methods 2002, 105(2):321-330.
88. Shukla A.A., Hubbard B., Tressel T., Guhan S., Low D. Downstream processing of monoclonal antibodies - application of platform approaches. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007, 848(1):28-39.
89. Simon O., Williams T., Caballero P., Lopez-Ferber M. Dynamics of deletion genotypes in an experimental insect virus population. Proc. Biol. Sci. 2006, 273(1588):783-790.
90. Specht R., Han B., Wickramasinghe S.R., Carlson J.O., Czermak P., Wolf A., Reif O.W. Densonucleosis virus purification by ion exchange membranes. Biotechnol. Bioeng. 2004, 88(4):465-473.
91. Strauss R., Huser A., Ni S., Tuve S., Kiviat N., Sow P.S., Hofmann C., Lieber A. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite protein. Mol. Ther. 2007, 15(1):193-202.
92. Summers M.D., Anderson D.L. Granulosis virus deoxyribonucleic acid: a closed, double-stranded molecule. J. Virol. 1972, 9(4):710-713.
93. Suzuki T., Chang M.O., Kitajima M., Takaku H. Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses. Cell. Immunol. 2010, 262(1):35-43.
94. Syed Musthaq S., Madhan S., Sahul Hameed A.S., Kwang J. Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in Penaeus monodon. Virology 2009, 391(2):315-324.
95. Teixeira A.P., Alves C., Alves P.M., Carrondo M.J., Oliveira R. Hybrid elementary flux analysis/nonparametric modeling: application for bioprocess control. BMC Bioinf. 2007, 8:30.
96. Teixeira A.P., Oliveira R., Alves P.M., Carrondo M.J. Advances in on-line monitoring and control of mammalian cell cultures: supporting the PAT initiative. Biotechnol. Adv. 2009, 27(6):726-732.
97. Teixeira A.P., Portugal C.A., Carinhas N., Dias J.M., Crespo J.P., Alves P.M., Carrondo M.J., Oliveira R. In situ 2D fluorometry and chemometric monitoring of mammalian cell cultures. Biotechnol. Bioeng. 2009, 102(4):1098-1106.
98. Thiem S.M., Miller L.K. Identification, sequence, and transcriptional mapping of the major capsid protein gene of the baculovirus Autographa californica nuclear polyhedrosis virus. J. Virol. 1989, 63(5):2008-2018.
99. Thomas C., Young N.J., Heaney J., Collins M.E., Brownlie J. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus. Vaccine 2009, 27(17):2387-2393.
100. Toledo A.L., Severo J.B., Souza R.R., Campos E.S., Santana J.C., Tambourgi E.B. Purification by expanded bed adsorption and characterization of an alpha-amylases FORILASE NTL from A. niger. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007, 846(1-2):51-56.
101. Transfiguracion J., Jorio H., Meghrous J., Jacob D., Kamen A. High yield purification of functional baculovirus vectors by size exclusion chromatography. J. Virol. Methods 2007, 142(1-2):21-28.
102. Troadec S., Bes C., Chentouf M., Nguyen B., Briant L., Jacquet C., Chebli K., Pugniere M., Roquet F., Cerutti M., Chardes T. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule. Clin. Immunol. 2006, 119(1):38-50.
103. Tweeten K.A., Bulla L.A., Consigli R.A. Characterization of an extremely basic protein derived from granulosis virus nucleocapsids. J. Virol. 1980, 33(2):866-876.
104. Urabe M., Ding C., Kotin R.M. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 2002, 13(16):1935-1943.
105. van Loo N.D., Fortunati E., Ehlert E., Rabelink M., Grosveld F., Scholte B.J. Baculovirus infection of nondividing mammalian cells: mechanisms of entry and nuclear transport of capsids. J. Virol. 2001, 75(2):961-970.
106. van Oers M.M. Opportunities and challenges of the baculovirus expression system. J. Invertebr. Pathol. 2011, 107:S3.
107. van Oers M.M., Thomas A.A., Moormann R.J., Vlak J.M. Secretory pathway limits the enhanced expression of classical swine fever virus E2 glycoprotein in insect cells. J. Biotechnol. 2001, 86(1):31-38.
108. van Reis R., Zydney A. Membrane separations in biotechnology. Curr. Opin. Biotechnol. 2001, 12(2):208-211.
109. van Reis R., Zydney A. Bioprocess membrane technology. J. Membr. Sci. 2007, 297:16-50.
110. Vicente T., Peixoto C., Carrondo M.J., Alves P.M. Purification of recombinant baculoviruses for gene therapy using membrane processes. Gene Ther. 2009, 16(6):766-775.
111. Vicente T., Peixoto C., Carrondo M.J., Alves P.M. Virus production for clinical gene therapy. Methods Mol. Biol. 2009, 542:447-470.
112. Vicente T., Mota J.P., Peixoto C., Alves P.M., Carrondo M.J. Analysis of adsorption of a baculovirus bioreaction bulk on an ion-exchange surface by surface plasmon resonance. J. Biotechnol. 2010, 148(4):171-181.
113. Vicente T., Mota J.P., Peixoto C., Alves P.M., Carrondo M.J. Modeling protein binding and elution over a chromatographic surface probed by surface plasmon resonance. J. Chromatogr. A 2010, 1217(13):2032-2041.
114. Vicente T., Peixoto C., Alves P.M., Carrondo M.J. Modeling electrostatic interactions of baculovirus vectors for ion-exchange process development. J. Chromatogr. A 2010, 1217(24):3754-3764.
115. Vicente, T., Roldão, A., Peixoto, C., Carrondo, M.J.T., Alves, P.M., 2011. Large scale production and purification of VLP based vaccines. J. Invertebr. Pathol. doi:10.1016/j.jip.2011.05.004.
116. Vieira H.L., Estevao C., Roldao A., Peixoto C.C., Sousa M.F., Cruz P.E., Carrondo M.J., Alves P.M. Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production. J. Biotechnol. 2005, 120(1):72-82.
117. Wang C.Y., Wang S. Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter. Gene Ther. 2006, 13(20):1447-1456.
118. Wang C.Y., Li F., Yang Y., Guo H.Y., Wu C.X., Wang S. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy. Cancer Res. 2006, 66(11):5798-5806.
119. Wright J.F., Le T., Prado J., Bahr-Davidson J., Smith P.H., Zhen Z., Sommer J.M., Pierce G.F., Qu G. Identification of factors that contribute to recombinant AAV2 particle aggregation and methods to prevent its occurrence during vector purification and formulation. Mol. Ther. 2005, 12(1):171-178.
120. Zhou J.X., Tressel T., Gottschalk U., Solamo F., Pastor A., Dermawan S., Hong T., Reif O., Mora J., Hutchison F., Murphy M. New Q membrane scale-down model for process-scale antibody purification. J. Chromatogr. A 2006, 1134(1-2):66-73.